No phaseStatus unknown
An Exploratory Clinical Trial of Ursodeoxycholic Acid for Early Diabetic Kidney Disease
- Sponsor
- The First Affiliated Hospital of Xi'an Jiaotong University
- Enrolment
- 30 planned
- Conditions
- Early-stage diabetic kidney disease
- Interventions
- Ursodeoxycholic acid Tablets (Pyrifos) (250mg*24 tablets per box)
- Ages
- adults, older adults
- Registry
- ChiCTR2600128420
Full record on the Chinese Clinical Trial RegistrySource: WHO ICTRP, processed 3 August 2026
Primary outcomes
- Urinary microalbumin/urinary creatinine
- Renal function (Scr, eGFR)
- Glycated hemoglobin (HbA1C);
History
Last registry update
Started
Registered